Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer

British Journal of Cancer

Volumn 97, Issue 9, 2007, Pages 1277-1286

  Kato, T ^a,b,d   Steers, G ^b   Campo, L ^b   Roberts, H ^b   Leek, R D ^b   Turley, H ^b   Kimura, T ^a   Kameoka, S ^a   Nishikawa, T ^a   Kobayashi, M ^a   Harris, A L ^c   Gatter, K C ^b   Pezzella, F ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d Onuma Hospital   (Japan)

Author keywords

Angiogenesis; Breast cancer; International differences; Microvessel density

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ANGIOGENESIS; ARTICLE; CANCER; CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY; FEMALE; HAZARD RATIO; HORMONAL THERAPY; HUMAN; JAPANESE; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVERALL SURVIVAL; PREVALENCE; PRIMARY INVASIVE BREAST CANCER; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; STATISTICAL ANALYSIS; SURVIVAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; AGING; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GREAT BRITAIN; HUMANS; JAPAN; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35648987915     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604015     Document Type: Article

References (47)

1. Axelsson K, Ljung BME, Moore II DH, Thor AD, Chew KL, Edgerton SM, Smith HS, Mayall BH (1995) Tumour angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 87: 997-1008
2. Beral V, Hermon C, Reeves G, Peto R (1995) Sudden fall in breast cancer death rates in England and Wales. Lancet 345: 1642-1643
3. Boyer-Chammard A, Tayler TH, Anton-Culver H (1999) Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev 23: 463-473
4. Braun KL, Fong M, Gotay C, Pagano IS, Chong C (2004) Ethnic difference in breast cancer in Hawaii: age, stage, hormone receptor status, and survival. Pacific Health Dialog 11: 146-153
5. Chaudary MA, Hayward JL, Bulbrook RD, Yoshida M, Miura S, Murai JT, Takatani O (1991) A comparison of epidemiological characteristics in breast cancer patients and normal patients in Great Britain and Japan: results of a prospective study. Breast Cancer Res Treat 18: S19-S22
6. Claus EB, Rish NJ, Thompson WD (1990) Age at onset as an indicator of familiar risk of breast cancer. Am J Epidemiol 131: 961-972
7. Costello P, McCann A, Carney DN, Dervan PA (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26: 1181-1184
8. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34: 187-202
9. Early Breast Cancer Trialist' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 patients. Lancet 339: 1-15
10. Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black patients in the United States. J Natl Cancer Inst 86: 705-712
11. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol 19: 403-410
12. Fox S, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283
13. Friedel GH, Millis RR, Sato T, Suichi T, Shikata I, Chaudary MA, Hayward JL (1991) Breast cancer in English and Japanese patients: prognostic significance of sinus histiocytosis and germinal center hyperplasia in axillary lymph nodes. Breast Cancer Res Treat 18: S73-S76
14. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F (1994) Tumour microvessel density, p53 expression, tumour size, and peritumoural lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
15. Gasparini G (2001) Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Oncol Hematol 37: 97-114
16. Gordon NH, Crowe JP, Brumberg DJ, Berger NA (1992) Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135: 609-618
17. Goulding H, Rashid NFNA, Robertson JF, Bell JA, Elston CW, Blamey RW, Ellis IO (1995) Assessment of angiogenesis in breast carcinoma: An important factor in prognosis? Hum Pathol 26: 1196-1200
18. Hansen S, Sorensen FB, Vach W, Grabau DA, Back M, Rose C (2004) Microvessel density compared with Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44: 428-436
19. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
20. Iscovich JM, Iscovich RB, Howe G, Shiboski S, Kaldor JM (1989) A case-control study of diet and breast cancer in Argentina. Int J Cancer 44: 770-776
21. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
22. Kasumi F, Yoshimoto M, Uchino J, Abe R, Nomura Y, Sugimachi K, Nakazato H, Abe O (2003) Meta-analysis of five studies on Tegafur plus Uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer. Oncology 64: 146-153
23. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2003) The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 88: 1900-1908
24. Kato T, Kameoka S, Kimura T, Soga N, Abe Y, Nishikawa T, Kobayashi M (2001) Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 70: 65-74
25. Kato T, Kimura T, Miyakawa R, Nobue I, Fujii A, Yamamoto K, Kameoka S, Toshio N, Kasajima T (1999) The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer. Breast Cancer Res Treat 53: 19-31
26. Kawamura T, Sobue T (2005) Comparison of breast cancer mortality in five countries: France, Italy, Japan, the UK and the USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol 35: 758-759
27. Kobayashi S (2004) What caused the decline in breast cancer mortality in the United Kingdom? Breast Cancer 11: 156-159
28. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170
29. Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, Riccobon A, Becciolini A, Bianchi S, Amadori D (2000) Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 89: 74-80
30. Merchant WJ, Millis RR, Smith P, Chaudary MA, Barnes DM (1999) Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese patients. Int J Cancer 84: 278-283
31. Morrison AS, Lowe R, MacMahan B, Ravnihar B, Yuasa Shu (1976) Some international differences in treatment and survival in breast cancer. Int J Cancer 18: 269-273
32. Natarajan N, Nemoto D, Nemoto T, Mettlin C (1988) Breast cancer survival among Orientals and whites in the United States. J Surg Oncol 39: 206-209
33. Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O (2005) Postoperative adjuvant therapy with Tamoxifen, Tegafur plus Uracil, or both in patients with node-negative breast cancer: a pooled analysis of six randomized controlled trials. J Clin Oncol 23: 2172- 2184
34. Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sakurai M, Sowa M (1995) Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer 71: 1297-1301
35. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M (2006) Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 118: 1635-1644
36. Sakamoto G, Sugano H, Hartman W (1981) Comparative pathological study of breast carcinoma among American and Japanese. In: Breast Cancer, McGuire WL (ed) pp 211 -231. Plenum Publishing Corporation: New York
37. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN (2002) Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132: 2307-2311
38. Simon MS, Severson RK (1996) Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer 77: 308-314
39. Tamakoshi K, Yatsuya H, Wakai K, Suzuki S, Nishio K, Lin Y, Niwa Y, Kondo T, Yamamoto A, Tokudome S, Toyoshima H, Tamakoshi A (2005) Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of JACC study. Cancer Sci 96: 57-62
40. The research Group for Population-based Cancer Registration in Japan (1999) Cancer incidence Japan. Gann Monograph Cancer Res 47: 83-143
41. The research Group for Population-based Cancer Registration in Japan (2003) Cancer incidence and incidence rates in Japan in 1998: estimates based on data from 12 population based cancer registries. Jpn J Clin Oncol 33: 241-245
42. Tominaga S, Kuroishi T (1995) Epidemiology of breast cancer. Breast Cancer 2: 1-7
43. Tsutsui S, Kume M, Era S (2003) Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer 10: 312-319
44. Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM (1993) Assessment of tumour vascularity as a prognostic factor in lymph node-negative invasive breast cancer. Eur J Cancer 29: 1141-1145
45. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumour angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
46. Wynder EL, Kajitani T, Kuno J, Lucas JC, DePalo A, Farrow J (1963) A comparison of survival rates between American and Japanese patients with breast cancer. Surg Gynecol Obstet 117: 196-200
47. Yonemoto RH (1980) Breast cancer in Japan and the United States-epidemiology, hormone receptors, pathology, and survival. Arch Surg 115: 1056-1062